October 20, 2022 – MyPeBS (My Personal Breast Cancer Screening) is a clinical study which aims to evaluate a breast cancer screening strategy based on individual risk. The clinical study, coordinated by Unicancer (France) involves 28 partners in 6 countries (Belgium,...

November 2021 – Unicancer announces that 20,000 women have already joined the MyPeBS (My Personal Breast Screening) study. This large international study, coordinated by France by Unicancer, started in summer 2019 and mobilises more than 300 recruiting sites in 6...

10,000 women needed in UK for an international trial that could revolutionise breast cancer screening Professor Fiona J Gilbert, national coordinator for UK, and participating women have been interviewed by ITV. Watch the video here

12 August 2021 Dr JB Burrion, MyPeBS Coordinator in Belgium, has been interviewed on RTBF Channel Watch the replay here

Come (virtually) and listen to Fiona Gilbert (University of Cambridge, UK) and Gareth Evans (Manchester University, UK) talk about early detection of cancer at the MAP (Molecular Analysis for Precision Oncology) 2021 virtual congress! The “early detection” session is...

Breast cancer: better screening for better care Already 10,000 women participating in MyPeBS! May, 2021 – Unicancer announces the inclusion of 10,000 female volunteers in the MyPeBS (My Personal Breast cancer Screening) study, almost half of whom were recruited in...

We are proud to share these recent relevant publications by the teams involved in MyPeBS consortium Harry de Koning and team (lead WP4 of MyPeBS) have recently published in the New England Journal of Medicine the final (and very expected) results of the NELSON trial,...

The MyPeBS consortium is proud to announce the publication of the Envision network consensus statement on personalized early detection and prevention of breast cancer. MyPeBS is one of the 5 founders of the ENVISION initiative Summary of the paper: “The European...

Primary Cancer Prevention Research in risk factors aiming for practical interventions Cancer Prevention in Europe Secondary Cancer Prevention Precision Prevention Prostate and Breast Cancer Screening Tertiary Cancer Prevention Improving life with and after cancer...

Four anti-screening collectives located in France, Italy, Belgium, and the United Kingdom recently published an "open letter" questioning the methodology and ethics of the MyPeBS study. Find here the answers of Dr Suzette Delaloge, MyPeBS Coordinating Investigator....

The first European conference on risk-stratified prevention and early detection of breast cancer was held from 26 to 28 June 2019 in Austria. The main objective was to pool knowledge and set actions towards implementation of risk-based breast cancer prevention and...

A woman’s risk of breast cancer is affected by her genetic make up.  Some bits of the normal genetic material (DNA) differs between one person and another: they are known as single nucleotide polymorphisms or SNPs.  Different combinations of these SNPs are associated...

Almost 100 partners as well as stakeholders of the project met in Paris on September 28th 2018 to prepare the launch of the MyPeBS clinical trial. It was the opportunity for all participants to get practical information on all operational aspects of the clinical...

All partners got together in Paris, on January 12th2018 for the first consortium meeting, to launch the MyPeBS project. Organizational and conceptual issues were discussed regarding the project and the clinical trial. This meeting also was the opportunity for many of...